Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXG4EO
|
||||
| Drug Name |
(R)-2-amino-4-(4-(difluoromethoxy)phenyl)-4-(4-fluoro-3-(3-fluoropropoxy)phenyl)-1-methyl-1H-imidazol-5(4H)-one
|
||||
| Synonyms |
CHEMBL1270029
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C20H19F4N3O3
|
||||
| Canonical SMILES |
CN1C(=N[C@](C1=O)(c2ccc(OC(F)F)cc2)c3ccc(F)c(OCCCF)c3)N
|
||||
| InChI |
InChI=1S/C20H19F4N3O3/c1-27-17(28)20(26-19(27)25,12-3-6-14(7-4-12)30-18(23)24)13-5-8-15(22)16(11-13)29-10-2-9-21/h3-8,11,18H,2,9-10H2,1H3,(H2,25,26)/t20-/m1/s1
|
||||
| InChIKey |
ZPKMNSUSQSIWHS-HXUWFJFHSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Renin, renal | Target Info | [1587926] | ||
| Cathepsin D | Target Info | [1587926] | |||
| BioCyc Pathway | Thyroid hormone biosynthesis | ||||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| Pathway Interaction Database | LKB1 signaling events | ||||
| Ceramide signaling pathway | |||||
| Direct p53 effectors | |||||
| Validated nuclear estrogen receptor alpha network | |||||
| PathWhiz Pathway | Angiotensin Metabolism | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.